Results 181 to 190 of about 64,954 (254)

Role of IL-5 in eosinophil-associated diseases and prospects for multi-target therapy. [PDF]

Front Immunol
Ou W, Wang Y, Hou C, Hou S, Zhou Y, Wang J, Wang Q.   +6 more
europepmc   +1 more source

Comparison of chimeric mouse-human and humanized anti-CD25 monoclonal antibodies for steroid-refractory acute graft-versus-host disease. [PDF]

Front Immunol
Zheng X, Zhou Y, Zheng Y, Lu N, Cao Y, Zhai W, Wei J, Yang D, Zhang R, Pang A, Feng S, Han M, Jiang E, Chen X.   +13 more
europepmc   +1 more source

Targeting the novel immune checkpoint KLRG1 is markedly therapeutic against cancer through multiple lymphocyte subsets. [PDF]

J Immunother Cancer
Jones TA, Shapiro JW, Sinicrope S, Li S, Yasuda K, Iovino M, Severe N, Pinkas J, Gajewski T.   +8 more
europepmc   +1 more source

Clinical application and optimization strategies for antibody-drug conjugates in solid tumors. [PDF]

J Int Med Res
Qu J, Zhao X, Zhang L, Cai W, Shen M, Liu X, Wei X, Fei F.   +7 more
europepmc   +1 more source

A novel bispecific antibody targeting OX40L and TNFα for the targeted treatment of rheumatoid arthritis. [PDF]

Antib Ther
Zhang Q, Song S.
europepmc   +1 more source

Progress in the Treatment of Refractory Myasthenia Gravis. [PDF]

Rev Neurol
Liu D, Mao J, Song J, Wang M.
europepmc   +1 more source

Blockade of CD155 and CD276 by Monoclonal Antibodies Fosters Immune Tolerance and Promotes Stable Engraftment of iPSC-Derived Islets in Allogeneic Humanized Mice. [PDF]

Transpl Int
Siracusano G, Deambrogio F, Sordi V, Malnati M, Piemonti L, Chimienti R.   +5 more
europepmc   +1 more source

Novel assays to assess the prevalence and neutralizing potential of anti-IdeS antibodies in healthy humans. [PDF]

Front Immunol
Hannachi E, Trecco A, Daventure V, Delignat S, Bonilla P, Lecerf M, Thaunat O, Dimitrov JD, Deligne C, Lacroix-Desmazes S.   +9 more
europepmc   +1 more source

Advances in Immune Checkpoint Inhibitors for Cancer Treatment. [PDF]

Cancers (Basel)
Chen K, Zhu F, Li X, Yoshimura T.
europepmc   +1 more source